LRIG3 anticorps
Aperçu rapide pour LRIG3 anticorps (ABIN7191315)
Antigène
Voir toutes LRIG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain
-
Purification
- Antigen affinity purification
-
Immunogène
- Synthetic peptide of Human LRIG3
-
Isotype
- IgG
-
-
-
-
Indications d'application
- ELISA:1:1000-1:5000, IHC:1:25-1:100,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
-
Autre désignation
- LRIG3
-
Sujet
-
Background: Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis. Lrig3 was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition of Lrig3 expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.
Aliases: Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody, LIG-3 antibody, LIG3 antibody, LRIG1-3 antibody, Lrig3 antibody, LRIG3_HUMAN antibody
-
UniProt
- Q6UXM1
Antigène
-